Two Sigma Investments, LP Eq Rx, Inc. Transaction History

Two Sigma Investments, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.66 - $2.31 $90,968 - $126,588	54,800 Added 45.97%	174,000 $386,000
Q2 2023 Aug 14, 2023	SELL	$1.61 - $1.96 $196,259 - $238,924	-121,900 Reduced 50.56%	119,200 $221,000
Q1 2023 May 15, 2023	BUY	$1.8 - $2.83 $355,860 - $559,491	197,700 Added 455.53%	241,100 $467,000
Q4 2022 Feb 14, 2023	BUY	$2.05 - $5.5 $88,969 - $238,700	43,400 New	43,400 $106,000

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.